Peak6 Investments LLC Sage Therapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023
SELL
$37.27 - $46.57 $2.88 Million - $3.6 Million
-77,200 Reduced 91.15%
7,500 $314,000
Q4 2022

Feb 10, 2023
SELL
$32.2 - $43.61 $463,680 - $627,984
-14,400 Reduced 14.53%
84,700 $3.23 Million
Q3 2022

Nov 14, 2022
BUY
$32.28 - $43.27 $3.2 Million - $4.29 Million
99,100 New
99,100 $3.88 Million

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
46.4M
Call Options Held
847K
Put Options Held
188K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email